Patient’s experience in the process of switching
| Questions | Answers | Participants (n=899) |
| n (%) | ||
| 1. Have you shared any concerns you may have with your consultant, specialist nurse, pharmacist or GP? | Yes | 388 (43) |
| No | 423 (47) | |
| I didn’t know I could | 87 (10) | |
| 2. Do you feel they have they offered you a satisfactory solution?*† | Yes, I was offered a switch back to my original treatment | 65 (7) |
| Yes, I was offered a switch to another treatment | 41 (5) | |
| No | 139 (15) | |
| Other free comment answers | 139 (15) | |
| 3. Did your consultant, specialist nurse or pharmacist seek your consent to switch from Humira to a biosimilar? | Yes | 359 (40) |
| No | 477 (53) | |
| Not sure/can’t remember | 63 (7) | |
| 4. Overall, how satisfied are you with your new biosimilar?‡ | Very satisfied | 74 (8) |
| Satisfied | 177 (20) | |
| Neither | 132 (15) | |
| Somewhat satisfied | 202 (23) | |
| Not at all satisfied | 307 (34) |
*The patients who answered ‘yes’ in question 1 (n=388) then proceeded to question 2. Four answers were missing in question 2.
†Patients responding to Q2 had the opportunity to do so in the form of free comment. Findings from the free comments and open questions were not formally analysed as a part of the present work.
‡Seven answers were missing in question 4.
GP, general practitioner.